Growth Metrics

Sanara MedTech (SMTI) Asset Writedowns and Impairment (2016 - 2025)

Sanara MedTech's Asset Writedowns and Impairment history spans 11 years, with the latest figure at $23.9 million for Q4 2025.

  • For Q4 2025, Asset Writedowns and Impairment rose 8131.93% year-over-year to $23.9 million; the TTM value through Dec 2025 reached $42.6 million, up 6486.4%, while the annual FY2025 figure was $28.3 million, 5326.57% up from the prior year.
  • Asset Writedowns and Impairment reached $23.9 million in Q4 2025 per SMTI's latest filing, up from $18.3 million in the prior quarter.
  • In the past five years, Asset Writedowns and Impairment ranged from a high of $23.9 million in Q4 2025 to a low of -$19750.0 in Q4 2023.
  • Average Asset Writedowns and Impairment over 5 years is $2.4 million, with a median of $95959.5 recorded in 2024.
  • Peak YoY movement for Asset Writedowns and Impairment: crashed 109.97% in 2023, then skyrocketed 18855.99% in 2025.
  • A 5-year view of Asset Writedowns and Impairment shows it stood at $44224.0 in 2021, then crashed by 121.27% to -$9406.0 in 2022, then plummeted by 109.97% to -$19750.0 in 2023, then surged by 1572.54% to $290827.0 in 2024, then skyrocketed by 8131.93% to $23.9 million in 2025.
  • Per Business Quant, the three most recent readings for SMTI's Asset Writedowns and Impairment are $23.9 million (Q4 2025), $18.3 million (Q3 2025), and $172679.0 (Q2 2025).